1·Objective to observe the influence of rosuvastatin or atorvastatin on platelet aggregation in patients treated with clopidogrel.
目的观察瑞舒伐他汀和阿托伐他汀对氯吡格雷抗血小板活性的影响。
2·Conclusion rosuvastatin and ezetimibe combination lipid-lowering effect is obvious, good efficacy, adverse reactions, is the ideal lipid-lowering program.
结论:瑞舒伐他汀与依折麦布联合使用,降脂效果明显,疗效好,不良反应少,是理想的降脂方案。
3·The invention belongs to the filed of medicine, in particular to a tablet containing Rosuvastatin calcium and a preparation process thereof.
本发明属医药领域,具体涉及一种瑞舒伐他汀钙的片剂及其制备工艺。
4·Conclusion: Rosuvastatin can effective treatment the elderly people which has coronary heart disease with paroxysmal atrial fibrillation.
结论:瑞舒伐他汀可有效治疗老年冠心病阵发性房颤。